1234 POSTER A First in Man Phase 1 Study of JNJ-26481585, a Novel Oral Histone Deacetylase Inhibitor (HDACi) in Advanced Cancer Patients -Evidence of Target Modulation, Antitumour Activity and Additional Safety Data in an Expanded Patient Cohort
Year: 2011
Type: article
Source: European Journal of Cancer
Authors: A. Omlin, B. Venugopal, R. Kristeleit, K. Shah, N. Fourneau, P. Hellemans, J. de Bono, R. Plummer, U. Banerji, J. Evans
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1983555687